Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway
about
Adjuvant-enhanced antibody responses in the absence of toll-like receptor signalingCross-Presentation of Cell-Associated Antigens by MHC Class I in Dendritic Cell SubsetsIntracellular nucleic acid sensors and autoimmunityCell death in the maintenance and abrogation of tolerance: the five Ws of dying cellsAntitumor immune responses mediated by dendritic cells: How signals derived from dying cancer cells drive antigen cross-presentationSelective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunityPrimary sterile necrotic cells fail to cross-prime CD8(+) T cellsDown regulation of genes involved in T cell polarity and motility during the induction of heart allograft tolerance by allochimeric MHC I.Commitment to the regulatory T cell lineage requires CARMA1 in the thymus but not in the periphery.Cyclophosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growth.Lampe1: an ENU-germline mutation causing spontaneous hepatosteatosis identified through targeted exon-enrichment and next-generation sequencing.Cutting edge: merocytic dendritic cells break T cell tolerance to beta cell antigens in nonobese diabetic mouse diabetes.Dendritic cell programming by cytomegalovirus stunts naive T cell responses via the PD-L1/PD-1 pathway.STING-mediated DNA sensing promotes antitumor and autoimmune responses to dying cells.Sensors of the innate immune system: their link to rheumatic diseases.Cholera toxin activates nonconventional adjuvant pathways that induce protective CD8 T-cell responses after epicutaneous vaccination.MFG-E8-mediated uptake of apoptotic cells by APCs links the pro- and antiinflammatory activities of GM-CSF.Loss of Phagocytic and Antigen Cross-Presenting Capacity in Aging Dendritic Cells Is Associated with Mitochondrial Dysfunction.An ENU mutagenesis approach to dissect "self"-induced immune responses: Unraveling the genetic footprint of immunosurveillance.Anti-IFN-α/β receptor antibody treatment ameliorates disease in lupus-predisposed miceCritical role of transmethylation in TLR signaling and systemic lupus erythematosus.Interactions of tumor cells with dendritic cells: balancing immunity and toleranceDissecting innate immunity by germline mutagenesis.Too dangerous to ignore: self-tolerance and the control of ignorant autoreactive T cells.Targeting intracellular signaling: a novel approach to vaccination.Tissue destruction caused by cytotoxic T lymphocytes induces deletional tolerance.Identification of a dendritic cell receptor that couples sensing of necrosis to immunity.Peptidases released by necrotic cells control CD8+ T cell cross-priming.NK-cell-mediated killing of target cells triggers robust antigen-specific T-cell-mediated and humoral responses.Breaking T cell tolerance to beta cell antigens by merocytic dendritic cellsImmunogenicity of necrotic cell death.Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells.Selective expansion of merocytic dendritic cells and CD8DCs confers anti-tumour effect of Fms-like tyrosine kinase 3-ligand treatment in vivo.Prolonged antigen storage endows merocytic dendritic cells with enhanced capacity to prime anti-tumor responses in tumor-bearing mice.A subset of human plasmacytoid dendritic cells expresses CD8α upon exposure to herpes simplex virus type 1.Cross-presentation of cell-associated antigens by mouse splenic dendritic cell populations.Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?Respond to "No antigen-presentation defect in Unc93b1(3d/3d) (3d) mice".Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells.Induction of Systemic Autoimmunity by a Xenobiotic Requires Endosomal TLR Trafficking and Signaling from the Late Endosome and Endolysosome but Not Type I IFN.
P2860
Q24684997-1E64670D-20C0-465A-8ED1-EF4844809ABAQ26799991-84180A67-B778-4485-B4F8-00D8F30E8BFEQ26997316-A039974F-CE31-45CB-AB0F-E7C2F8D19B3DQ26999223-59279A46-50BD-4FC8-959A-2B28EAD20F7DQ27026193-731DDC31-C8AC-4708-89F3-77C32306457FQ28250405-F31C5B5B-D4CC-4B33-AA70-ED9029F83D25Q28279623-546A575A-290B-496D-A020-D7B8E1D86C1CQ30940459-5C8210DB-13F0-476B-A520-EDD8FA080935Q33414811-914CA866-D4B5-4837-9F4C-A0F8E2978BB9Q33502208-7BA87D72-1BCD-40B2-BBDF-03EF5B589850Q33961657-24719007-A062-46DB-BB64-B7B23633AFF3Q34047889-F90F7428-992D-4A35-B611-700794AEC760Q34589567-0FAB4865-4EC3-4AED-8A9E-1AAC0FE0A663Q34646599-8B84DACC-05D0-4B1B-A188-259949D96B05Q35623130-76AFD800-7733-45A5-9328-D843D3DD2343Q35750997-3F9ADE7A-2DEB-4772-88D6-D0B6EB190051Q35826586-35E40F7E-E14C-44A3-8868-69497913EF97Q36031500-53BC7FC2-8DF1-4F24-8E1C-D164D65B3E0BQ36373362-089AC5C7-1B84-4795-8BF9-5DBBE23E3567Q36490737-5B8EFE33-5E94-4383-A538-EB5C4BF1C30BQ36791474-41EC6593-53CA-4A83-BD15-A9CD28D4DC9DQ36975749-33FADA93-9AB9-4462-9B3F-4785D4C4E3C4Q37060493-940A3E04-B84A-42BE-B047-71CD2928E3C4Q37070256-CF6322F1-ECDD-43DB-8123-50D7D58C3164Q37123459-7C037CE8-747F-4DA8-ADF9-76018D32F434Q37129429-B474D4E1-1E9B-4FB1-85D5-091BEFD61C9DQ37164859-B95E39FA-F6FF-4213-A98D-2BC7DA450ABBQ37259198-3F2CEC2F-811E-40F1-9A3C-28B75FBB2914Q37262370-F7C67C0E-C8AF-47EC-A10D-389ACA69D1C4Q37373748-C263FEA0-A2DF-4889-98A0-7EE896B65171Q38255959-3CC399A9-8D10-4B43-AB18-47FF4F9E2218Q39501063-54EE9865-3D91-4E83-9090-49702B3D015AQ39607848-07C6403F-15C8-47CA-B833-5EA946CA46BBQ39665878-E7113F16-E25A-4D87-8219-2CC59E726B67Q41155777-B85BB3D5-8884-4D00-A06D-6F21E93F6B74Q42144716-3DFB2675-31B3-420C-83CE-CE89300F5605Q42245307-0FA727BF-27EF-4319-950C-3F031A1623A7Q44575639-143E9885-5D00-4838-8327-8B8BEA349D85Q45386474-1BD6A695-3B36-423B-A675-1007F03E1C13Q47621572-C7D43CD9-8234-470A-A877-B9517647E0D8
P2860
Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway
@ast
Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway
@en
Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway
@nl
type
label
Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway
@ast
Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway
@en
Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway
@nl
prefLabel
Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway
@ast
Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway
@en
Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway
@nl
P2093
P50
P1433
P1476
Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway
@en
P2093
Argyrios N Theofilopoulos
Edith Janssen
Keith S Bahjat
Sara McBride
P304
P356
10.1016/J.IMMUNI.2006.03.024
P407
P577
2006-06-01T00:00:00Z